Complimentary Webinar:

An Introduction to Next-Generation Liquid Biopsy Providing A Better Look at Residual Cancer

 

Thursday, December 8, 2022  | 12:00 pm – 1:00 pm ET

Click below to register

There is no fee to attend, but registration is required.

 

About the Webinar:

Minimal residual disease has emerged as a key biomarker in oncology therapy development and patient care.

In this webinar, the audience will learn how a next-generation liquid biopsy can identify evidence of post-treatment cancer cells. Providing high levels of sensitivity for residual disease, this test can delineate potential treatment options.

Attendees will learn:

  • The role of next-generation liquid biopsy assays in enabling much earlier detection of disease recurrence
  • The utility of such biopsies in more disease indications and at earlier stages of disease
  • Liquid biopsy’s role in patient enrichment, screening/enrollment and surrogate endpoint analysis for clinical trials

Intended for:

This webinar will be of interest to pharma and biotech translational researchers who are developing drugs to combat cancer. Attendees will walk away with a better understanding of this test, and the applications to their own work.

 

About the Speaker:

 

Erin Newburn, PhD, is Sr Director, Field Applications Scientist at Personalis, Inc. Dr joined Personalis as a Field Applications Scientist in 2013 with over 12 years of research experience in the areas of molecular biology, genetics, and biotechnology. Dr Newburn completed her postdoctoral training at the National Institute of Mental Health (NIMH) investigating candidate susceptibility genes for major psychiatric illnesses. Dr Newburn received her PhD from the Ohio State University in Integrated Biomedical Science as a Presidential Fellow.

 

 

About the Webinar’s Associated Conference:

 

Immuno-Oncology 360˚ (IO360°) is a four-day conference that convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers. The 2023 IO360° conference will take place February 7-10, 2023 New York Marriott at the Brooklyn Bridge, Brooklyn, NY.

 

Click below to register

There is no fee to attend, but registration is required.